维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Sucak"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Hepatitis B-related events in autologous hematopoietic stem cell transplantation recipients显示文摘AIM: To investigate the frequency of occult hepatitis B, the clinical course of hepatitis B virus (HBV) reactivation and reverse seroconversion and associated risk factors in autologous hematopoietic stem cell transplantation (HSCT) recipients. METHODS: This study was conducted in 90 patients undergoing autologous HSCT. Occult HBV infection was investigated by HBV-DNA analysis prior to transplantation, while HBV serology and liver function tests were screened prior to and serially after transplantation. HBV-related events including reverse seroconversion and reactivation were recorded in all patients. RESULTS: None of the patients had occult HBV prior to transplantation. Six (6.7%) patients were positivefor HBV surface antigen (HBsAg) prior to transplantation and received lamivudine prophylaxis; they did not develop HBV reactivation after transplantation. Clinical HBV infection emerged in three patients after transplantation who had negative HBV-DNA prior to HSCT. Two of these three patients had HBV reactivation while one patient developed acute hepatitis B. Three patients had anti-HBc as the sole hepatitis B-related antibody prior to transplantation, two of whom developed hepatitis B reactivation while none of the patients with antibody to HBV surface antigen (anti-HBs) did so. The 14 anti-HBs-and/or anti-HBc-positive patients among the 90 HSCT recipients experienced either persistent (8 patients) or transient (6 patients) disappearance of anti-HBs and/or anti-HBc. HBsAg seroconversion and clinical hepatitis did not develop in these patients. Female gender and multiple myeloma emerged as risk factors for loss of antibody in regression analysis (P < 0.05). CONCLUSION: Anti-HBc as the sole HBV marker seems to be a risk factor for reactivation after autologous HSCT. Lamivudine prophylaxis in HbsAg-positive patients continues to be effective.	zcan eneli Zübeyde Nur zkurt Kadir Acar Seyyal Rota Sahika Zeynep Aki Zeynep Arzu Yegin Münci Yagci Seren zenirler Gülsan Türkz Sucak	2010	World Journal of Gastroenterology2010，16，14：	3
2	The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors显示文摘	Gungor T Kanat-Pektas M Sucak A	2009	Arch Gynecol Obstet2009，279，1：	1
3	The role of thrombocyto- sis in prognostic evaluation of epithelial ovarian tumors 显示文摘	Gungor T Kanat-Pektas M Sucak A	2009	Arch Gvnecol Obstet2009，279，1：	1
4	A prospective study on chemo- therapy-induced hepatitis B virus reactivation in chronic HBsAg carriers with hematologic malignancies and pretemptive therapy with nucleoside analoguez 显示文摘	Yagci M Acar K Sucak GT	2006	Leuk Lymphoma2006，47，8：	1
5	The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors显示文摘	Gungor T Kanat-Pektas M Sucak A	2009	Arch Gynecol Obstet2009，279，1：	1
6	A prospectivestudy on chemo therapy induced hepatitis B virus reactivation in chronic HB sAg carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues显示文摘	Yageci M Acar K Sucak GT	2006	Leuk Lymphoma2006，47，8：	1
7	The role of thrombocytosis in prognostic evaluation of epithelialovarian tumors 显示文摘	GUNGOR T KANAT PEKTAS M SUCAK A	2009	Arch Gynecol Obstet2009，279，1：	1
8	Clinical and electrophysiological evaluation of patients with thalidomide- induced neuropathy 显示文摘	Kocer B Sucak G Kuruoglu R	2009	Acta Neurol Belg2009，109，2：	1
9	The role of thrombocy- tosis in prognostic evaluation of epithelial ovarian tumors显示文摘	Gungor T Kanat - Pektas M Sucak A	2009	Arch Gynecol Obstet2009，279，1：	1
10	Inflammatory markers, oxidative stress, and antioxidant capacity in healthy allo -HSCT donors during hematopoietic stem cell mobilization 显示文摘	Cigdem llhan Elif Suyani Gulsan Sucak	2015	J Clin Apher2015，30，4：	1
11	The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors显示文摘	Gungor T Kanat-Pektas M Sucak A	2009	Arch Gynecol Obstet2009，279，1：	1
12	Thrombopoietic cytokines and platelet count in multiple myeloma显示文摘	Ozkurt ZN Yagci M Sucak GT	2010	Platelets2010，21，1：	1
13	A prospective study on chemotherapyinduced hepatitis B virus reactivation in chronic HBsAg carriers with hematologic malignancies and preemptive therapy with nucleoside analogues 显示文摘	Yagci M Acar K Sucak GT	2006	Leuk Lymphoma2006，47，8：	1
14	The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors显示文摘	Gungor T Kanat-Pektas M Sucak A	2009	Arch Gynecol Obstet2009，279，1：	1
15	Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia显示文摘	Sucak G T Acar K Sucak A	2006	Blood Coagul Fibrinolysis2006，17，5：	1
16	Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices 显示文摘	Celen S Moroy P Sucak A	2004	Contraception2004，69，：	1
17	Allogeneic stem cell transplantation for severe aplastic anemia:Graft rejection remains a problem显示文摘	Aki SZ Sucak GT Ozkurt ZN	2009	Transfus Apher Sci2009，40，1：	1
18	Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia显示文摘	Sucak G T Acar K Sucak A	2006	Blood Coagul Fibrinolysis2006，17，5：	1
19	Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT显示文摘	Suyani E Sucak GT Yagci M	2011	Ann Hematol2011，90，6：	1
20	Osteonecrosis of the jaw in patients with multiple myeloma treated with zzoledronic acid显示文摘	Cetiner S Sucak G T Kahraman S A	2009	J Bone Miner Metab2009，27，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示